WELL Health Technologies Corp (WELL – Research Report) has received a rating update from a Wall Street analyst yesterday. Maxim Group’s analyst Allen Klee reiterates their Buy rating on the shares, with a C$10.00 price target.
According to TipRanks.com, Klee is ranked 0 out of 5 stars with an average return of -18.6% and a 23.8% success rate. Klee covers the Technology sector, focusing on stocks such as T Stamp, Inc. Class A, Research Solutions, and Iveda Solutions.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for WELL Health Technologies Corp with a C$9.06 average price target, a 90.3% upside from current levels. In a report issued on July 13, Haywood also maintained a Buy rating on the stock with a $8.00 price target.
WELL Health Technologies Corp’s market cap is currently C$1.12B and has a P/E ratio of -252.66.
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: Clinical services, Digital services, and others. It also engages in the Electronic Medical Records business that supports the digitization of clinics. Its objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.
The company’s shares closed last Friday at C$4.75.
Read More on TSE:WELL:
